To replicate the environment of SIRS in vitro, we treated the human monocytic cell line THP-1 with lipopolysaccharide (LPS); a PAMP that induces monocyte activation via TLR-4 signaling. The gene discussed is TLR4; the disease is systemic inflammatory response syndrome.